The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease

被引:61
|
作者
Glodzik-Sobanska, Lidia
Pirraglia, Elizabeth
Brys, Miroslaw
de Santi, Susan
Mosconi, Lisa
Rich, Kenneth E.
Switalski, Remigiusz
Saint Louis, Leslie
Sadowski, Martin J.
Martiniuk, Frank
Mehta, Pankaj [2 ]
Pratico, Domenico [3 ]
Zinkowski, Raymond P. [4 ]
Blennow, Kaj
de Leon, Mony J. [1 ,5 ]
机构
[1] NYU, Sch Med, Dept Psychol, Ctr Brain Hlth, New York, NY 10016 USA
[2] New York State Off Mental Retardat & Dev Disabil, Inst Basic Res, Staten Isl, NY USA
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Appl NeuroSolut, Vernon Hills, IL USA
[5] Nathan Kline Inst Orangeburg, Orangeburg, NY USA
关键词
Biomarkers; Cerebrospinal fluid; Alzheimer's disease; Normal aging; CEREBROSPINAL-FLUID TAU; APOLIPOPROTEIN-E GENOTYPE; MILD COGNITIVE IMPAIRMENT; AMYLOID-BETA-PEPTIDE; PHOSPHORYLATED TAU; DIFFERENTIAL-DIAGNOSIS; BIOCHEMICAL MARKER; LIPID-PEROXIDATION; OXIDATIVE STRESS; EPSILON;
D O I
10.1016/j.neurobiolaging.2007.08.019
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
While cerebrospinal fluid (CSF) biomarkers are of use in the prediction and diagnosis of Alzheimer's disease our understanding of the background effects of age and the ApoE genotype is limited. Seventy-eight community-based normal volunteers (mean age 60 +/- 10 years, range 36-86) were examined to determine the relationships between CSF measures of total tau (T-tau), hyperphosphorylated tau (P-tau 231), amyloid beta (A beta 42/A beta 40 ratio), and isoprostane (IP) with age and ApoE genotype. The results showed that age by epsilon 4 genotype interactions were found for P-tau231 (beta = 1.82; p < 0.05) and IP (beta = 1.6; p < 0.05). T-tau CSF concentration increased with age. The increasing CSF concentrations of P-tau and IP in epsilon 4 carriers suggest that early tauopathy and oxidative stress may be related to the increased risk for AD. The data also suggest that T-tau changes are more age dependent than A beta changes. The evidence that P-tau231 and IP are the earliest markers for the neuronal damage related to AD awaits longitudinal study. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:672 / 681
页数:10
相关论文
共 50 条
  • [1] Joint Effect of Hypertension and APOE Genotype on CSF Biomarkers for Alzheimer's Disease
    Kester, Maartje I.
    van der Flier, Wiesje M.
    Mandic, Gorana
    Blankenstein, Marinus A.
    Scheltens, Philip
    Muller, Majon
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (04) : 1083 - 1090
  • [2] Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population
    Monge-Argiles, J. A.
    Gasparini-Berenguer, R.
    Gutierrez-Agullo, M.
    Munoz-Ruiz, C.
    Sanchez-Paya, J.
    Leiva-Santana, C.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [3] Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease
    Morris, Jill K.
    Uy, Roxanne Adeline Z.
    Vidoni, Eric D.
    Wilkins, Heather M.
    Archer, Ashley E.
    Thyfault, John P.
    Miles, John M.
    Burns, Jeffrey M.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2017, 58 (04) : 1129 - 1135
  • [4] CSF Biomarkers in Alzheimer's Disease and Controls: Associations with APOE Genotype are Modified by Age
    Kester, Maartje I.
    Blankenstein, Marinus A.
    Bouwman, Femke H.
    van Elk, Evert J.
    Scheltens, Philip
    van der Flier, Wiesje M.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (03) : 601 - 607
  • [5] Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype
    Mofrad, Rosha Babapour
    Tijms, Betty M.
    Scheltens, Philip
    Barkhof, Frederik
    van der Flier, Wiesje M.
    Sikkes, Sietske A. M.
    Teunissen, Charlotte E.
    [J]. NEUROLOGY, 2020, 95 (17) : E2378 - E2388
  • [6] Influence of the ApoE genotype on serum APOE levels in Alzheimer's disease patients
    Corzo, L
    Fernandez-Novoa, L
    Zas, R
    Beyer, K
    Lao, JI
    Alvarez, XA
    Cacabelos, R
    [J]. PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 765 - 771
  • [7] Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging
    Abner, Erin L.
    Jicha, Gregory A.
    Shaw, Leslie M.
    Trojanowski, John Q.
    Goetzl, Edward J.
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (05): : 399 - 403
  • [8] ApoE genotype influences the CSF level of A beta 42 in Alzheimer's disease
    Seubert, PA
    Motter, RN
    Schenk, DB
    Lieberburg, IM
    Kholodenko, D
    Galasko, D
    Thomas, R
    Chang, L
    Miller, B
    Clark, C
    Knopman, DS
    Kaye, J
    Green, RC
    Kertiles, L
    Bashirzadeh, R
    Boss, MA
    [J]. NEUROLOGY, 1997, 48 (03) : 63006 - 63006
  • [9] CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's disease
    Samuels, SC
    Silverman, JM
    Marin, DB
    Peskind, ER
    Younki, SG
    Greenberg, DA
    Schnur, E
    Santoro, J
    Davis, KL
    [J]. NEUROLOGY, 1999, 52 (03) : 547 - 551
  • [10] The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease
    Loewe, Luise Christine
    Gaser, Christian
    Franke, Katja
    [J]. PLOS ONE, 2016, 11 (07):